UK - Oxfam and FairPensions have warned investing in pharmaceutical companies that try to block poor countries' access to affordable drugs might damage reputations and lead to falling returns.
Richard English, trade campaign manager at Oxfam, said pension holders had a right to know how their money was being invested: “By voicing your concerns in this way, you could be helping to secure ...
To continue reading this article...
Join Professional Pensions
Become a Professional Pensions Lite Member today
In just a few clicks you can start your free Professional Pensions Lite membership for 12 months, providing you access to:
- Three complimentary articles per month covering the latest real-time news, analysis and opinion from the industry
- Receive important and breaking news stories via our two daily news alerts
- Hear from industry experts and other forward-thinking leaders
Are you a trustee, investment consultant or in-house pension and benefit scheme professional? You can apply for full complimentary access here
